153 related articles for article (PubMed ID: 11962333)
1. Prognostic markers in prostate cancer.
Ross JS; Sheehan CE; Fisher HA; Kauffman RA; Dolen EM; Kallakury BV
Expert Rev Mol Diagn; 2002 Mar; 2(2):129-42. PubMed ID: 11962333
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors in prostate cancer: current concepts from the 1999 College of American Pathologists Conference on Solid Tumor Prognostic Factors and the 1999 World Health Organization Second International Consultation on Prostate Cancer.
Bostwick DG; Foster CS
Semin Urol Oncol; 1999 Nov; 17(4):222-72. PubMed ID: 10632123
[TBL] [Abstract][Full Text] [Related]
3. Morphologic and molecular prognostic markers in prostate cancer.
Ross JS; Sheehan CE; Dolen EM; Kallakury BV
Adv Anat Pathol; 2002 Mar; 9(2):115-28. PubMed ID: 11917165
[TBL] [Abstract][Full Text] [Related]
4. College of American Pathologists Conference XXVI on clinical relevance of prognostic markers in solid tumors. Report of the Prostate Cancer Working Group.
Grignon DJ; Hammond EH
Arch Pathol Lab Med; 1995 Dec; 119(12):1122-6. PubMed ID: 7503660
[TBL] [Abstract][Full Text] [Related]
5. Molecular markers of prostate cancer outcome.
Quinn DI; Henshall SM; Sutherland RL
Eur J Cancer; 2005 Apr; 41(6):858-87. PubMed ID: 15808955
[TBL] [Abstract][Full Text] [Related]
6. Current and proposed biologic markers in prostate cancer: 1994.
Bostwick DG; Qian J
J Cell Biochem Suppl; 1994; 19():197-201. PubMed ID: 7823592
[No Abstract] [Full Text] [Related]
7. Biomolecular markers of outcome prediction in prostate cancer.
Lopergolo A; Zaffaroni N
Cancer; 2009 Jul; 115(13 Suppl):3058-67. PubMed ID: 19544547
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in prostate cancer.
Ross JS; Jennings TA; Nazeer T; Sheehan CE; Fisher HA; Kauffman RA; Anwar S; Kallakury BV
Am J Clin Pathol; 2003 Dec; 120 Suppl():S85-100. PubMed ID: 15298146
[TBL] [Abstract][Full Text] [Related]
9. College of American Pathologists Conference XXVI on clinical relevance of prognostic markers in solid tumors. Report of the Colorectal Cancer Working Group.
Fielding LP; Pettigrew N
Arch Pathol Lab Med; 1995 Dec; 119(12):1115-21. PubMed ID: 7503659
[TBL] [Abstract][Full Text] [Related]
10. Molecular and prognostic markers in prostate cancer. A study of cell-cycle regulators, angiogenesis and candidate markers.
Halvorsen OJ
APMIS Suppl; 2008; (123):5-62. PubMed ID: 18771090
[No Abstract] [Full Text] [Related]
11. Prognostic value of serum markers for prostate cancer.
Stenman UH; Abrahamsson PA; Aus G; Lilja H; Bangma C; Hamdy FC; Boccon-Gibod L; Ekman P
Scand J Urol Nephrol Suppl; 2005 May; (216):64-81. PubMed ID: 16019759
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review.
Singhal S; Vachani A; Antin-Ozerkis D; Kaiser LR; Albelda SM
Clin Cancer Res; 2005 Jun; 11(11):3974-86. PubMed ID: 15930332
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens.
Amin M; Boccon-Gibod L; Egevad L; Epstein JI; Humphrey PA; Mikuz G; Newling D; Nilsson S; Sakr W; Srigley JR; Wheeler TM; Montironi R
Scand J Urol Nephrol Suppl; 2005 May; (216):20-33. PubMed ID: 16019757
[TBL] [Abstract][Full Text] [Related]
14. Prognostic relevance of molecular markers of oral cancer--a review.
Schliephake H
Int J Oral Maxillofac Surg; 2003 Jun; 32(3):233-45. PubMed ID: 12767868
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and predictive factors in prostate cancer: historical perspectives and recent international consensus initiatives.
Srigley JR; Amin M; Boccon-Gibod L; Egevad L; Epstein JI; Humphrey PA; Mikuz G; Newling D; Nilsson S; Sakr W; Wheeler TM; Montironi R
Scand J Urol Nephrol Suppl; 2005 May; (216):8-19. PubMed ID: 16019756
[TBL] [Abstract][Full Text] [Related]
16. College of American Pathologists Conference XXVI on clinical relevance of prognostic markers in solid tumors. Summary. Members of the Cancer Committee.
Henson DE; Fielding LP; Grignon DJ; Page DL; Hammond ME; Nash G; Pettigrew NM; Gorstein F; Hutter RV
Arch Pathol Lab Med; 1995 Dec; 119(12):1109-12. PubMed ID: 7503658
[No Abstract] [Full Text] [Related]
17. The reporting of prostate cancer on needle biopsy: prognostic and therapeutic implications and the utility of diagnostic markers.
Zhou M; Epstein JI
Pathology; 2003 Dec; 35(6):472-9. PubMed ID: 14660096
[TBL] [Abstract][Full Text] [Related]
18. [Markers for diagnosis, prediction and prognosis of prostate cancer].
Taskén KA; Angelsen A; Svindland A; Eide T; Berge V; Wahlquist R; Karlsen S
Tidsskr Nor Laegeforen; 2005 Dec; 125(23):3279-82. PubMed ID: 16327854
[TBL] [Abstract][Full Text] [Related]
19. Molecular prognostic markers in pancreatic cancer.
Ghaneh P; Kawesha A; Evans JD; Neoptolemos JP
J Hepatobiliary Pancreat Surg; 2002; 9(1):1-11. PubMed ID: 12021893
[TBL] [Abstract][Full Text] [Related]
20. Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors.
Brown JE; Cook RJ; Major P; Lipton A; Saad F; Smith M; Lee KA; Zheng M; Hei YJ; Coleman RE
J Natl Cancer Inst; 2005 Jan; 97(1):59-69. PubMed ID: 15632381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
